Eg 427 Revenue

Biotechnology Research • Paris, Île-de-France, France • 21-50 Employees

Eg 427 revenue & valuation

Annual revenue	$2,053,320
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$6,600,000
Total funding	$33,800,000

Key Contacts at Eg 427

Philippe Chambon

Co-Founder, Chairman And Ceo

Pierre Denys

Associate Founder

François Giuliano

Co-Founder

Company overview

Headquarters	29, Rue du Faubourg Saint-Jacques, Paris, Île-de-France 75014, FR
Website	eg427.com
NAICS	541714
Keywords	Gene Therapy, Hsv-1 Vector Platform, Herpes Type 1 Gene Therapy Platform, Neurogenic Bladder, Peripheral Nervous System Disorders, Urinary Bladder Dysfunction, Treatment Of Nervous System Disorders
Founded	2019
Employees	21-50
Socials

Eg 427 Email Formats

Eg 427 uses 5 email formats. The most common is {first initial} (e.g., j@eg427.com), used 50% of the time.

Format	Example	Percentage
{first initial}	j@eg427.com	50%
{first name}	john@eg427.com	15%
{first name}.{last name}	john.doe@eg427.com	15%
{first initial}.{last name}	j.doe@eg427.com	10%
{first initial}{last name}	jdoe@eg427.com	5%

About Eg 427

At EG427 our unique, non-replicative Herpes Simplex Virus type 1 (HSV-1) based vector platform called HERMES, delivers, with pinpoint precision, highly selective, durable expression of disease modifying transgenes to address prevalent diseases in neurology. Our lead asset EG110A, for the treatment of neurogenic bladder dysfunction, has received IND clearance in June 2024 from the US FDA. Our revolutionary approach to the treatment of this disease aims at providing patients with a comprehensive, long-term solution to their bladder management, through a highly selective molecular biology approach overcoming the drawbacks of current standard of care. Our HQ and labs are in Paris, France, where we were founded in 2019. We have raised over USD 21 million, including from our Series A in 2021.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

C-Suite

Entry

Manager

Employees by Department

Eg 427 has 10 employees across 5 departments.

Departments

Number of employees

Funding Data

Explore Eg 427's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-08-13	4	$5,600,000
2025-03-20	5	$28,200,000

Funding Insights

$33,800,000

Total funding amount

$28,200,000

Most recent funding amount

Number of funding rounds

Frequently asked questions

Eg 427 is located in Paris, Île-de-France, FR.

Eg 427 generates an estimated annual revenue of $2,053,320. This revenue figure reflects the company's market position and business performance in its industry.

Eg 427 has an estimated valuation of $6,600,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Eg 427 was founded in 2019, making it 7 years old. The company has established itself as a significant player in its industry over this time.

Eg 427 has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Eg 427 has raised a total of $33,800,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.